These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30553206)

  • 21. Development of Rifapentine-Loaded PLGA-Based Nanoparticles: In vitro Characterisation and in vivo Study in Mice.
    Liang Q; Xiang H; Li X; Luo C; Ma X; Zhao W; Chen J; Tian Z; Li X; Song X
    Int J Nanomedicine; 2020; 15():7491-7507. PubMed ID: 33116484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy.
    Maretti E; Costantino L; Buttini F; Rustichelli C; Leo E; Truzzi E; Iannuccelli V
    Drug Deliv Transl Res; 2019 Feb; 9(1):298-310. PubMed ID: 30484257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery.
    Song X; Lin Q; Guo L; Fu Y; Han J; Ke H; Sun X; Gong T; Zhang Z
    Pharm Res; 2015 May; 32(5):1741-51. PubMed ID: 25407545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced cellular uptake of a new, in silico identified antitubercular candidate by peptide conjugation.
    Horváti K; Bacsa B; Szabó N; Dávid S; Mező G; Grolmusz V; Vértessy B; Hudecz F; Bősze S
    Bioconjug Chem; 2012 May; 23(5):900-7. PubMed ID: 22515329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surface Layer Modification of Poly(d,l-lactic- co-glycolic acid) Nanoparticles with Targeting Peptide: A Convenient Synthetic Route for Pluronic F127-Tuftsin Conjugate.
    Horváti K; Gyulai G; Csámpai A; Rohonczy J; Kiss É; Bősze S
    Bioconjug Chem; 2018 May; 29(5):1495-1499. PubMed ID: 29669198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanostructured lipid carriers for incorporation of copper(II) complexes to be used against
    Sato MR; Oshiro Junior JA; Machado RT; de Souza PC; Campos DL; Pavan FR; da Silva PB; Chorilli M
    Drug Des Devel Ther; 2017; 11():909-921. PubMed ID: 28356717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mannosylated graphene oxide as macrophage-targeted delivery system for enhanced intracellular M.tuberculosis killing efficiency.
    Pi J; Shen L; Shen H; Yang E; Wang W; Wang R; Huang D; Lee BS; Hu C; Chen C; Jin H; Cai J; Zeng G; Chen ZW
    Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109777. PubMed ID: 31349400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Increase of antituberculosis efficiency of rifampicin embedded into phospholipid nanoparticles with sodium oleate].
    Sanzhakov MA; Ipatova OM; Torkhovskaya TI; Tikhonova EG; Medvedeva NV; Zakharova TS; Prozorovskiy VN
    Biomed Khim; 2018 Nov; 64(6):505-510. PubMed ID: 30632978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Respirable rifampicin-based microspheres containing isoniazid for tuberculosis treatment.
    Cassano R; Trombino S; Ferrarelli T; Mauro MV; Giraldi C; Manconi M; Fadda AM; Picci N
    J Biomed Mater Res A; 2012 Feb; 100(2):536-42. PubMed ID: 22162280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid nanoparticles coated with chitosan using a one-step association method to target rifampicin to alveolar macrophages.
    Vieira ACC; Chaves LL; Pinheiro M; Lima SC; Neto PJR; Ferreira D; Sarmento B; Reis S
    Carbohydr Polym; 2021 Jan; 252():116978. PubMed ID: 33183580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective Effect of Rifampicin Loaded by HPMA-PLA Nanopolymer on Macrophages Infected with Mycobacterium Tuberculosis.
    Yang G; Wang G; Liu L; Zhai K; Chen X; Chen Y; Wu L
    Comput Math Methods Med; 2022; 2022():5784283. PubMed ID: 35027942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted delivery of rifampicin to tuberculosis-infected macrophages: design, in-vitro, and in-vivo performance of rifampicin-loaded poly(ester amide)s nanocarriers.
    Amarnath Praphakar R; Munusamy MA; Sadasivuni KK; Rajan M
    Int J Pharm; 2016 Nov; 513(1-2):628-635. PubMed ID: 27693734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxicity effects of AgZnO nanoparticles and rifampicin on Mycobacterium tuberculosis into the macrophage.
    Jafari A; Jafari Nodooshan S; Safarkar R; Movahedzadeh F; Mosavari N; Novin Kashani A; Dehghanpour M; Kamalzadeh M; Rasouli Koohi S; Fathizadeh S; Majidpour A
    J Basic Microbiol; 2018 Jan; 58(1):41-51. PubMed ID: 29105782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis.
    Rawal T; Parmar R; Tyagi RK; Butani S
    Colloids Surf B Biointerfaces; 2017 Jun; 154():321-330. PubMed ID: 28363192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
    De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
    J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gelatin nanocarriers as potential vectors for effective management of tuberculosis.
    Saraogi GK; Gupta P; Gupta UD; Jain NK; Agrawal GP
    Int J Pharm; 2010 Jan; 385(1-2):143-9. PubMed ID: 19819315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitubercular Nanocarrier Combination Therapy: Formulation Strategies and in Vitro Efficacy for Rifampicin and SQ641.
    D'Addio SM; Reddy VM; Liu Y; Sinko PJ; Einck L; Prud'homme RK
    Mol Pharm; 2015 May; 12(5):1554-63. PubMed ID: 25811733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alternative Pharmaceutical Formulation for Oral Administration of Rifampicin.
    Halicki PCB; Hädrich G; Boschero R; Ferreira LA; von Groll A; da Silva PEA; Dora CL; Ramos DF
    Assay Drug Dev Technol; 2018 Dec; 16(8):456-461. PubMed ID: 30325673
    [No Abstract]   [Full Text] [Related]  

  • 39. Delivery of LLKKK18 loaded into self-assembling hyaluronic acid nanogel for tuberculosis treatment.
    Silva JP; Gonçalves C; Costa C; Sousa J; Silva-Gomes R; Castro AG; Pedrosa J; Appelberg R; Gama FM
    J Control Release; 2016 Aug; 235():112-124. PubMed ID: 27261333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rifampicin Nanoformulation Enhances Treatment of Tuberculosis in Zebrafish.
    Trousil J; Syrová Z; Dal NK; Rak D; Konefał R; Pavlova E; Matějková J; Cmarko D; Kubíčková P; Pavliš O; Urbánek T; Sedlák M; Fenaroli F; Raška I; Štěpánek P; Hrubý M
    Biomacromolecules; 2019 Apr; 20(4):1798-1815. PubMed ID: 30785284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.